Tech Company Financing Transactions
Iconic Therapeutics Funding Round
Iconic Therapeutics secured a $20 million Series B financing round on 4/16/2014. Investors included H.I.G. Capital, Lundbeckfond Ventures and MPM Capital.
Transaction Overview
Company Name
Announced On
4/16/2014
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors
Proceeds Purpose
The company has completed a successful Phase 1 clinical trial in the U.S. and is planning an international Phase 2 study.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
701 Gateway Blvd. 100
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Greene
Chief Medical Officer
Gabriela Burian
Chief Operating Officer
Brandon Smith
VP - Operations
Cynthia Porter
Browse more venture capital transactions:
Prev: 4/16/2014: Paperless Post venture capital transaction
Next: 4/16/2014: Procurify venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs